InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-14.8%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Olson Kenneth Fletcher, Chief Operating Officer. Insider active across 2 companies, notably HARVARD BIOSCIENCE INC. In total, 6 reports have been recorded. History available since 11 June 2021. The latest transaction was filed on 29 December 2021 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
2,812 shares@ US$7.2732.4% of flowCommon StockSEC:0000921895-21-002906
2,812 shares@ US$7.270.060% mcap32.4% of flowCommon StockSEC:0000921895-21-002906:0
1,539 shares@ US$7.370.033% mcap17.6% of flowCommon StockSEC:0000921895-21-002516:0
1,539 shares@ US$7.3717.6% of flowCommon StockSEC:0000921895-21-002516
18,378 shares0Common StockSEC:0000921895-21-001648
18,378 shares0Common StockSEC:0000921895-21-001648:0
6 of 6 declarations
About Olson Kenneth Fletcher
Kenneth Fletcher Olson is the Chief Operating Officer at Harvard Bioscience Inc. He oversees the company's operations, playing a key role in operational efficiency and strategy implementation.
